Ronny Drapkin

Department of Medical Oncology, Dana-Farber Cancer Institute

Affiliated withDana-Farber Cancer Institute Boston, MA Brigham and Women's Hospital

Research Area

Biography

Ronny Drapkin has not added Biography.
If you are Ronny Drapkin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 29	2011

Other Publications

Article	Year
BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell\| PubMed ID: 12419249	2002
The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell\| PubMed ID: 12732143	2003
Unilateral transverse arm defect with subterminal digital nubbins. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society\| PubMed ID: 14692649	2003
The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 14983014	2004
Association of BRCA1 with the inactive X chromosome and XIST RNA. Philosophical transactions of the Royal Society of London. Series B, Biological sciences\| PubMed ID: 15065664	2004
Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia. Human pathology\| PubMed ID: 15297969	2004
Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes & development\| PubMed ID: 15713842	2005
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer research\| PubMed ID: 15781627	2005
The distal fallopian tube: a new model for pelvic serous carcinogenesis. Current opinion in obstetrics & gynecology\| PubMed ID: 17218844	2007
A recurrent mutation in PALB2 in Finnish cancer families. Nature\| PubMed ID: 17287723	2007
Further evidence for BRCA1 communication with the inactive X chromosome. Cell\| PubMed ID: 17350581	2007
Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clinical medicine & research\| PubMed ID: 17456833	2007
Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications. The American journal of surgical pathology\| PubMed ID: 17460458	2007
Serous carcinogenesis in the fallopian tube: a descriptive classification. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists\| PubMed ID: 18156967	2008
A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology\| PubMed ID: 18242217	2008
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecologic oncology\| PubMed ID: 18342932	2008
Does the fimbria have an embryologic origin distinct from that of the rest of the fallopian tube? Fertility and sterility\| PubMed ID: 18353321	2008
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18451228	2008
Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists\| PubMed ID: 18580316	2008
A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18628483	2008
Urokinase-type plasminogen activator receptor: a beacon of malignancy? Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18794069	2008
New insights into the pathogenesis of serous ovarian cancer and its clinical impact. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18854563	2008
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18927287	2008
Ovarian cancer pathogenesis: a model in evolution. Journal of oncology\| PubMed ID: 19746182	2010
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology\| PubMed ID: 19912369	2009
Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival. Neoplasia (New York, N.Y.)\| PubMed ID: 20126474	2010
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells. Cancer cell\| PubMed ID: 20227043	2010
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. The American journal of surgical pathology\| PubMed ID: 20414098	2010
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nature structural & molecular biology\| PubMed ID: 20453858	2010
STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis. Frontiers in bioscience (Elite edition)\| PubMed ID: 21196340	2011
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21502498	2011
A comprehensive analysis of PAX8 expression in human epithelial tumors. The American journal of surgical pathology\| PubMed ID: 21552115	2011
Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecologic oncology\| PubMed ID: 21683992	2011
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21746896	2011
Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphol... The American journal of surgical pathology\| PubMed ID: 21921781	2011
High throughput interrogation of somatic mutations in high grade serous cancer of the ovary. PloS one\| PubMed ID: 21931712	2011
Rethinking ovarian cancer: recommendations for improving outcomes. Nature reviews. Cancer\| PubMed ID: 21941283	2011
The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. Gynecologic oncology\| PubMed ID: 22019526	2012
Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science (New York, N.Y.)\| PubMed ID: 22033517	2011
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. Gynecologic oncology\| PubMed ID: 22037318	2012
The new face of ovarian cancer modeling: better prospects for detection and treatment. F1000 medicine reports\| PubMed ID: 22076125	2011
ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers. PloS one\| PubMed ID: 22279592	2012